Since progression of NAFLD may also comprise development of fibrosis, Sirius Red staining was performed and mRNA and protein expression of several markers, such as Col1a1, Col1a2, αSMA and hydroxyproline, were investigated (Figure S3). This evidence concerns the gene COL1A2 and metabolic dysfunction-associated steatotic liver disease.